QIAGEN Marks 4,000th QIAcube Connect Placement, Reaffirming Leadership in Automated Sample Processing QIAcube Connect drives lab efficiency by automating critical steps in molecular biology workflows ...
Portfolio expansion reinforces QIAGEN’s leadership in automated solutions for non-invasive liquid biopsy applications combined with complete workflows // New ccfDNA Kit upgrade with urine protocol for ...
VENLO, Netherlands, & GERMANTOWN, Maryland--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the 4,000th placement of its QIAcube Connect instrument, a significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results